HUMAN EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR SEQUENCE RECOGNIZED BY EGF COMPETITIVE MONOCLONAL-ANTIBODIES - EVIDENCE FOR THE LOCALIZATION OF THE EGF-BINDING SITE
- 15 October 1989
- journal article
- research article
- Vol. 264 (29) , 17469-17475
Abstract
Epitopes recognized by three epidermal growth factor (EGF) competitive monoclonal antibodies, LA22, LA58, and LA90, have been localized to a 14-amino acid region in the extracellular domain of the human EGF receptor. The binding of each of these mutually competitive antibodies to A431 epidermoid carcinoma cells was inhibited up to 87% by EGF. Furthermore, binding to A431 cells was inhibited 100% by the EGF competitive monoclonal antibody 528 IgG. The EGF receptor monoclonal antibody 455 IgG, which recognizes a blood group A-related carbohydrate modification of A431 receptors and does not inhibit EGF binding did not inhibit the binding of these three antibodies to A431 cells. Antibodies LA22, LA58, and LA90 were unusual in that they bound to recognized denaturated and endoglycosidase F-treated antigenic determinants in Western blots. This suggested that the antibodies recognized continuous peptide epitopes. The epitopes for these antibodies were first localized in cyanogen bromide- and V8 protease-generated fragments of a truncated form of the EGF receptor secreted by A431 cells. In experiments with synthetic peptides, all three antibodies were found to bind to the 14 amino acids from Ala-351 to Asp-364 of the mature human EGF receptor. These amino acids are located between the two Cys-rich regions of the extracellular domain of the receptor, and they include an Agr-Gly-Asp-Ser recognition site for adhesion molecule receptors. The homologous sequence in the chicken EGF receptor, which binds mouse EGF with a 100-fold lower affinity than the human EGF receptor, contains four amino acid differences including two in the Arg-Gly-Asp-Ser tetramer. The mutually competitive binding of EGF and antibodies LA22, LA58, and LA90 implied that the amino acids between Ala-351 and Asp-364 participated in the formation of the EGF-binding site of the human EGF receptor.This publication has 29 references indexed in Scilit:
- Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.Proceedings of the National Academy of Sciences, 1983
- Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells.Journal of Biological Chemistry, 1982
- “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AAnalytical Biochemistry, 1981
- Proteolytic domains of the epidermal growth factor receptor of human placentaJournal of Supramolecular Structure and Cellular Biochemistry, 1981
- Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes.Journal of Biological Chemistry, 1980
- Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.Journal of Biological Chemistry, 1980
- A New Mouse Myeloma Cell Line that Has Lost Immunoglobulin Expression but Permits the Construction of Antibody-Secreting Hybrid Cell LinesThe Journal of Immunology, 1979
- Influence of lectins on the binding of 125I-labeled EGF to human fibroblastsBiochemical and Biophysical Research Communications, 1977
- Nerve growth factor receptors on human melanoma cells in culture.Proceedings of the National Academy of Sciences, 1977
- Structural Analysis of the Peptides Derived from Specific Acid-Catalyzed Hydrolysis at Aspartylprolyl Peptide Bonds in Human J ChainThe Journal of Immunology, 1977